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Edited by Sandro SonninoAbstract A murine lung alveolar carcinoma cell line (WT-
Line 1) and its equally tumorigenic but non-malignant deriva-
tive transduced with a dominant negative inhibitor of NF-jB
(mI-jB-Line 1), were proﬁled on the Aﬀymetrix 19000 gene
array platform. Two diﬀerentially expressed gene clusters were
identiﬁed and integrated into a functional model. The down-
regulation of anti-oxidant defenses, in mI-jB-Line 1 cells, cor-
relates with high levels of reactive oxygen species (ROS) and
ROS damage to cellular macromolecules while the upregula-
tion of metabolic nuclear receptors correlates with an adap-
tive/survival response, which involves a shift in energy
metabolism toward b-oxidative respiration. Accordingly, mI-
jB-Line 1 cells are markedly sensitized to pharmacologic inhi-
bition of b-oxidative respiration. These ﬁndings are indicative
of compensatory changes that could undermine anti-cancer
therapies targeting NF-jB.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Glycolysis; b-Oxidation1. Introduction
The NF-jB/Rel proteins are a family of dimeric transcription
factors with a characteristic N-terminal 300 amino-acid motif,
called the Rel homology domain (RHD). The RHD is impli-
cated in protein dimerization and DNA binding to jB elements
within the promoter sequence of target genes. The C-terminus
of nuclear factor kappa B (NF-jB)/Rel proteins distinguishes
two classes: Class I includes NF-jB1 (p105/p50) and NF-jB2
(p100/p52) proteins, characterized by C-termini with inhibitory
ankyrin repeats (a 33 amino-acid motif), that is cleaved-oﬀ to
yield a truncated protein with avid DNA binding activity yet
devoid of transcriptional activity. Consequently, homodimersAbbreviations:WT, wild type; mI-jB, mutant I kappa B alpha; NF-jB,
nuclear factor kappa B; ATP, adenosine-tri-phosphate; ROS, reactive
oxygen species; TMZ, trimetazidine; 2DG, 2-deoxyglucose
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doi:10.1016/j.febslet.2005.11.018of class I NF-jB proteins are by default, transcriptional repres-
sors. Class II includes c-Rel (and its viral homolog v-Rel), RelB
and RelA (p65) proteins, characterized by a potent C-terminal
trans-activation domain. However, class II NF-jB proteins are
not eﬀective DNA binders and consequently, they heterodimer-
ize with class I NF-jB proteins to form eﬀective DNA binding
and transcription activating complexes. While this is the central
dogma of the structure–function–activity of NF-jB proteins,
there are important variations of exquisite biological relevance
[1].
The tissue distribution, activation pathways, and the pheno-
typic changes associated with speciﬁc gene deletions (‘‘knock-
outs’’), indicate distinct and sometimes overlapping functions
for individual NF-jB/Rel proteins [2–4, and references there-
in]. While NF-jB1, NF-jB2, RelB and c-Rel knockouts dem-
onstrate immune defects speciﬁc to B, T and dendritic cell
function, the RelA (p65) knockout is lethal, due to massive
apoptosis. In regards to their tissue distribution, NF-jB2,
Rel-B and c-Rel expression are more restricted to the immu-
no-hematopoetic compartment, while NF-jB1 and RelA
(p65) are ubiquitously expressed. In regards to the activation
mechanism, two distinct pathways are described [5]. Rel/NF-
jB complexes are retained in the cytosol by association with
the ankyrin repeats of inhibitory kappa B (IjB) proteins
and/or the self-inhibitory ankyrin repeats of NF-jB1/p105
and NF-j B2/p100 [2,3]. Activating signals proceed by activat-
ing IjB kinases (IKKs), which phosphorylate and signal for
the ubiquitination and proteosomal degradation of IjBs [5].
Similarly, the inhibitory ankyrin repeats are cleaved-oﬀ NF-
jB1/p105 and NF-jB2/p100 to yield p50 and p52, respectively.
Removal of these inhibitory protein motifs, allows for the for-
mation and nuclear translocation of active Rel/NF-jB com-
plexes. IKKs are large multimeric complexes consisting of
either IKKa or IKKb and its regulatory subunit IKKc [6].
Engagement of antigen, pathogen and the TNF family of
receptors in immune cells, results in signals that converge on
IKKa activating the non-canonical NF-jB pathway, which in-
volves the processing of p100 to p52 and nuclear translocation
of p52 and RelB complexes. On the other hand, a variety of
signals converge on IKKb/c and activate the canonical NF-
jB pathway, which involves IjB degradation and nuclear
translocation of p50/RelA and p50/c-Rel complexes. How cells
discriminate and utilize these distinct activation pathways is
not fully understood.blished by Elsevier B.V. All rights reserved.
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ator of immune responses and a pivotal transcription factor in
chronic inﬂammatory processes A contributory and sometimes
causal association between chronic immune-mediated and
inﬂammatory processes, and malignant transformation/pro-
gression has been observed in laboratory and clinical cancer
models [7–10]. At the molecular level, there is corroborative
evidence to the hyper-activation of NF-jB in transformed cells
[11–13] and its implication in growth, the subversion of apop-
tosis, the promotion of neo-angiogenesis, invasive growth and
the formation of distant metastases [14,15]. Thus, NF-jB has
emerged as a highly sought after cancer drug target in spite
of unsubstantiated concerns that its essential role in a broad
range of cellular and biological processes, makes it a non-spe-
ciﬁc thus potentially pernicious drug target. Noteworthy,
many pharmacologic agents with potent NF-jB inhibitory
activity have been used extensively in humans and without sig-
niﬁcant adverse eﬀects [16,17]. This underscores the plasticity
of biological systems, in terms of homeostatic control mecha-
nisms, which, given the disparate biology of transformed (can-
cerous) versus normal cells, provides a basis for selective kill or
as the case may be, selective survival.
In the present study, we attempt to shed some light on the
homeostatic controls and survival mechanisms that accom-
pany NF-jB inhibition, by contrasting a murine lung alveolar
carcinoma cell line (WT-Line 1) and its equally tumorigenic
but non-malignant derivative (mI-jB-Line 1) transduced with
a dominant negative inhibitor of NF-jB [15]. The intriguing
phenotype of mutant I kappa B alpha (mI-jB)-Line 1 cells
(sustained proliferation) is in fact just one, in the spectrum
of responses that accompany the inhibition of NF-jB in vari-
ous model systems, which also include frank apoptosis to pro-
liferation arrest. We thus sought to address the adaptive/
compensatory mechanisms that are operative in this model sys-
tem, axing our investigation on fundamental biochemical and
metabolic pathways. We provide microarray expression data
on 19000 genes from both WT-Line 1 and mI-jB-Line 1 cells;
we perform pair wise comparisons and statistical transforma-
tions of the 19000 gene dataset to extract diﬀerentially
expressed genes in mI-jB-Line 1 cells; we identify two diﬀeren-
tially expressed gene clusters comprised of downregulated anti-
oxidant enzymes and upregulated metabolic nuclear receptors.
Accordingly, we demonstrate that mI-jB-Line 1 cells contain
higher levels of reactive oxygen species (ROS) and ROS dam-
age to cellular macromolecules, yet, survive in part, by shiftingChip
type
Sample
name
b-Actin GAPDH Backg
Mu19A WT2 1.1 1.0 834
WT3 1.3 0.88 526
mI-jB1 1.3 1.0 502
mI-jB2 1.22 0.91 826
Mu19B WT2 1.0 1.0 602
WT3 1.3 0.89 460
mI-jB1 1.4 1.0 581
mI-jB2 1.3 0.95 612
Mu19C WT2 1.1 1.0 580
WT3 1.0 1.6 736
mI-jB1 1.4 0.9 542
mI-jB2 1.4 1.3 642energy metabolism toward fatty acid oxidation (b-oxidative
respiration).2. Materials and methods
2.1. Reagents
Trimetazidine dihyrochloride (Laboratoires Servier – France), an
inhibitor of the terminal enzyme in b-oxidation, long chain 3-keto-acyl
thiolase, was freshly reconstituted in water to obtain a 0.1 M stock
solution. The glucose analog and anti-metabolite, 2-deoxyglucose,
was purchased from Sigma and reconstituted in water to obtain a
10 M stock solution. The Lipid Peroxidation Assay Kit (Cat
#437634) was purchased from Calbiochem, the ApoAlert CPP32/Cas-
pase 3 colorimetric assay kit (Cat #630216) was purchased from Clon-
tech and the adenosine-tri-phosphate (ATP) determination kit from
Molecular Probes. Antibodies for 4-hyroxynonenal (Cat #24325),
Mn superoxide dismutase (Cat #24323), Cu/Zn superoxide dismutase
(Cat #24322) and Catalase (Cat #24316) were purchased from Oxis
Research (Portland, Oregon).
2.2. Cell lines and cell culture
The murine lung alveolar carcinoma cell line, Line 1, was generously
provided by Dr. Edith Lord. Cells were cultured in DMEM supple-
mented with 10% FBS and 1% penicillin/streptomycin, and maintained
at 37 C in a 95% humid atmosphere, with 5% CO2. Line 1 cells were
stably transduced with either an empty vector cassette or with a dom-
inant negative inhibitor of NF-jB (mI-jB) to obtain WT-Line 1 and
mI-jB-Line 1 cells as previously described [15].
2.3. Microarray expression analyses, pair wise comparisons and
statistical transformations of datasets
2 separate RNA batches were obtained from both WT-Line 1 and
their equally tumorigenic but non-malignant isogenic derivative (mI-
jB-Line 1) transduced with a dominant negative inhibitor of NF-jB
[15]. All RNA samples were of high quality as indicated by the pattern
of staining with ethidium bromide in an agarose gel after electropho-
retic separation. RNA was probed with Aﬀymetrix Mu19 high-density
oligonucleotide arrays, which have approximately 19000 probe sets.
Twelve arrays were examined, representing duplicate for each sample
on 3 sets (A,B,C). Analytical procedures were carried out using stan-
dard operating procedures developed and validated by the University
of Rochester Microarray Core Facility. After hybridization and wash-
ing, arrays were stained with phycoerythrin–streptavidin, which binds
to the biotinylated cRNAs hybridized with the probes. The initial scan
detected the ﬂuorescence of the phycoerythrin–streptavidin. After the
initial scan, signals were ampliﬁed by staining the array with biotin-la-
beled anti-streptavidin antibody followed by phycoerythrin–streptavi-
din.
Analyses of the antibody-enhanced scans are presented. Data from
scans can be retrieved from the AMDeC microarray resource center
gene expression database (http://www.amdec.org/core_research/in-
dex.htm).round Std deviation
background
Noise Scaling factor
57.6 24.2 2.2
71.6 15.6 2.6
102 15.6 2.0
58.7 23.33 2.7
36 18.9 1.9
47.9 14.6 2.5
40.6 18.1 1.8
35 19.1 2.3
19 17 2.2
43 23 1.5
75.5 16.5 2.3
30 19 2.9
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samples were subjected to 4 pair wise comparative analyses. A regres-
sion model was done for each pair of samples, and the inverse gradient
of the slope of the line of best ﬁt (correlation coeﬃcient 0.95) used as
the re-scaling multiplicative factor for each gene in the experimental
group (mI-jB).2.4. Analyzing for anti-oxidant enzyme gene and protein expression
RT-PCR was used to assess the expression levels of critical anti-oxi-
dant enzymes, manganese superoxide dismutase (MnSOD), copper/zn
superoxide dismutase (Cu/ZnSOD), catalase (CAT) and glutathione
peroxidase (GPX), in WT and mI-jB-Line 1 tumor cells. Brieﬂy,
1 lg of total RNA was reversed transcribed with in a 20 ll volume
of Superscript II (Invitrogen) following the manufacturers instructions
and then diluted 5-fold in RNAse free water. Two micro litres of the
cDNA thus obtained, was admixed with 16 ll of PCR Supermix
(GibcoBrl), 1 ll of the primer mix and 1 ll of the ﬂuorescent DNA
intercalating dye (Sybr Green at at 1:3000 dilution in water), and
ampliﬁed in the real-time PCR machine (Rotorgene 2000, Robocycler,
Phenix Research).
Cell homogenates (50 lg of protein) were fractionated by SDS–
PAGE on a 15% acrylamide gel and the proteins thus resolved, were
transferred to polyvinylidene diﬂuoride (PVDF) membranes (Millipore
Corp., Bedford, MA) and the PVDF membranes were probed for
MnSOD, Cu/ZnSOD, CAT using their respective antibodies as previ-
ously described [15].able 1
uppression of NF-jB signaling activity in Line 1 tumor cells, does not
ﬀect cellular proliferation in vitro and tumorigenesis in vivo but
gniﬁcantly decreases metastatic progression [9]
Proliferation Tumorigenesis Metastases
T-Line 1 19000 ± 630 4.973 ± 109 13 ± 3
I-jB-Line 1 19373 ± 385 4.868 ± 134 3 ± 1*
) Proliferation was determined by measuring the incorporation of
dioactive thymidine into DNA. The results express the radioactivity
f incorporated thymidine (cpm) and represents the average ± S.E. of2.5. Analyzing for cellular levels of ROS and ROS damage to cellular
macromolecules
ROS levels were assessed by labeling cells with the redox sensitive,
cell permeable ﬂuorescent probe dicholorﬂuoresceine [0.4 lM] for
15 min and assessing for spectral changes with a ﬂuorescence acti-
vated cell sorter. Lipid peroxidation was assessed with the Lipid
Peroxidation Assay Kit (Calbiochem Cat #437634) per the manufac-
turers instructions. Protein adducts were detected by staining cells
with the 4-hydroxynonenal antibody (Oxis Research, Portland, Ore-
gon). Brieﬂy, cells were cultured on glass slides, permeablised by
incubating 0.1% Triton in PBS (washing solution) for 5 min, incu-
bated for 30 min in a 5% solution of FBS in PBS (blocking solu-
tion) and for 1 h in a 1:500 dilution of the 4-hydroxynonenal
antibody in blocking solution. After three consecutive washes, the
slides were incubated in a 1:1000 dilution of the Rhodamine conju-
gated secondary antibody (Bio-Rad) for 30 min, subjected to three
consecutive washes, coversliped and image analyzed with an inverted
ﬂuorescent microscope. The single-cell gel electrophoresis (or comet)
assay is a rapid and sensitive ﬂuorescence microscopic method for
the detection of primary DNA damage at the individual cell level.
We utilized the comet assay to assess genotoxicity in WT and mI-
jB-Line 1 cells by a previously described method [18]. All proce-
dures were carried out under dim light. Brieﬂy, cells were harvested
by scraping into culture medium, washed in phosphate buﬀered sal-
ine (PBS), pelleted and resuspended in 75 ll of 0.5% low melting
point agarose (LMP), layered onto a slide pre-coated with 0.5% nor-
mal melting point (NMP) agarose, coversliped and allowed to solid-
ify for 5 min at 4 C. Subsequently, another layer of NMP (75 ll)
was added and allowed to solidify and the coverslip removed. Slides
were then immersed in cold lysis buﬀer (2.5 M NaCl, 100 mM
EDTA, 10 mM Tris (pH 10) and 1% of Triton X-100) at 4 C for
1 h and then immersed in the electrophoresis buﬀer (1 mM EDTA,
300 mM NaOH) for 30 min following by a 30 min electrophoresis
at 25 V and 250 mA. Slides were subsequently neutralized by gently
washing in 0.4 M Tris (pH 7.5), stained with 25 ll of ethidium bro-
mide (20 mg/ml) and examined under a ﬂuorescent microscope at
200· magniﬁcation and photographed. 50 cells were image analyzed
using a system based on the NIH image scientiﬁc image-processing
program [19].ur independent experiments. (B) Tumorigenesis was assessed by
jecting 2 · 105 tumor cells in the thigh muscle of syngenic Balb/cByJ
ice. The results express the tumor weight (grams), taken from 12
ice, 25 days post tumor cell inoculation. (C) Metastasis was assessed
y counting pulmonary metastatic tumor nodules. The results express
e number of nodules observed in the lungs of 12 mice, 25 days post
mor cell inoculation.
ndicates a statistically signiﬁcant diﬀerence (P < 0.0001).2.6. Analyzing for apoptotic cell death and cellular ATP levels in
response to metabolic inhibitors
Cellular apoptosis was assessed with the Caspase 3 activation kit
(Clontech) per the manufacturers instructions. Cellular ATP levels
were measured with the ATP determination kit (Molecular Probes)
per the manufacturers instructions. Cell viability was determined byTrypan blue exclusion. Brieﬂy, cells were trypsinized and 10 ll of a
0.5% trypan blue solution was added to 100 ll of cell suspension and
counted for Trypan blue negative cells. The viable cell count was used
to normalize for cellular ATP content across treatment groups.
2.7. Statistical analyses
Experiments were performed in triplicates and the results express the
standard error of the mean. Statistical comparisons were done with the
Students t-test and ANOVA.3. Results and discussion
3.1. Suppression of NF-jB signaling activity does not aﬀect Line
1 cell proliferation in vitro and tumorigenesis in vivo but
markedly suppresses malignant proclivity
NF-jB is hyper-activated in cancer cells and has been impli-
cated in tumor growth, the subversion of apoptosis, the pro-
motion of neo-angiogenesis, invasive tumor growth and
metastasis [11–15]. It is however noted that NF-jB proteins,
with the exception of the oncogenic viral protein v-Rel and
its homolog, c-Rel, have no independent cell transforming
ability [20] but serve a secondary albeit essential role, i.e., the
adaptive/survival response to extrinsic/epigenetic and intrin-
sic/genetic stressors [9].
We previously demonstrated that suppression of NF-jB
(p50/p65) signaling activity in Line 1 cancer cells by stable
transduction of a dominant negative inhibitor of NF-jB, did
not compromise cellular proliferation in vitro and tumorigen-
esis in vivo but markedly suppressed spontaneous pulmonary
metastasis from a voluminous primary tumor site in the thigh
(Table 1) [15]. These results indicate that compensatory
changes occur that allow for sustained cellular proliferation
and tumor growth in spite of the suppression of NF-j B signal-
ing activity.
3.2. Microarray expression proﬁling and pair-wise analyses of
parental Line 1 cancer cells (WT-Line 1) and their equally
tumorigenic but non-malignant counterparts stably
transduced with a dominant negative inhibitor of NF-jB
(mI-jB-Line 1)
To understand the distinct biology of WT-Line 1 and their
equally tumorigenic but non-malignant derivatives transduced
with a dominant negative inhibitor of NF-jB (mI-jB-Line 1),T
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V.B. Andela et al. / FEBS Letters 579 (2005) 6814–6820 6817we performed a highthroughput gene expression analysis using
the Aﬀymetrix 19000 gene array platform. After pair wise
comparisons and statistical transformations of the 19000 gene
datasets (see methods and supplemental data) we identiﬁed
two diﬀerentially expressed functional gene clusters comprised
of: I – Stress defense and repair genes and II – Nuclear Hor-
mone Receptors (NHRs) and modulators of NHR function
(Fig. 1). The dowregulation of stress defense and repair genes
in mI-j B-Line 1 cancer cells is consistent with the role of NF-
jB as a stress-sensor that enacts a stress-alleviating response.
We previously reconciled the upregulation of NHRs in mI-
jB-Line 1 cancer cells to its mutually and functionally antag-
onistic interactions with NF-jB [21,22].
3.3. Downregulation of anti-oxidant enzymes correlates with a
higher levels of reactive oxygen species (ROS) and ROS
macromolecular damage in mI-jB-Line 1 cells
Reactive oxygen species (ROS), produced in large part, by
the mitochondrial respiratory chain and to a lesser extent, by
oxidative reactions in the cytoplasm, constitute a major source
of endogenous stress [23,24]. At physiologic concentrations,
ROS have signaling functions, which amongst others, includes
the activation of NF-jB and the induction of anti-oxidant gene
expression [25]. In pathologic states characterized by an excess
of endogenous production, an excess of exposure to exogenous
sources or a reduction in antioxidant defense capacity, ROS
damage cellular macromolecules and compromise cellular
functions [26–28].
Consistent with the role of NF-jB in the induction of anti-
oxidant gene expression, we observe a downregulation of crit-
ical anti-oxidant defense enzymes in mI-jB-Line 1 cells at the
gene (Fig. 2A) and protein levels (Fig. 2B) and a corresponding
increase in cellular ROS levels (Fig. 2C) and ROS induced
damage to lipids (Fig. 2D), proteins (Fig. 2E) and DNA
(Fig. 2F). In spite of a high oxidative state, mI-jB-Line 1 cells
survive and even have the capacity to further sustain exoge-Fig. 1. Microarray proﬁling and diﬀerential gene expression analysis of WT-
We provide raw expression data (supplemental datasets A, B and C), a comp
D). Downregulated stress response and repair genes and upregulated nucle
identiﬁed in the comparative dataset, and displayed as a color-coded graphinous oxidative stress, such as treatment with as much as
100 mM hydrogen peroxide (H2O2) in cell culture (data not
shown). This ‘‘antiapoptotic state’’ in spite of chronic oxida-
tive stress, has important implications in cancer therapeutics
granted radiotherapy, photodynamic therapy and chemother-
apy are in great part dependent on the induction of oxidative
stress and tumor cell apoptosis.
3.4. Upregulation of metabolic nuclear receptors correlates with
a compensatory shift in energy metabolism towards fatty
acid oxidation (b-oxidative respiration)
Because the mitochondrial respiratory chain is the major site
of ROS production, cells must strike a balance between energy
production and redox homeostasis. Cancer cells have high
metabolic rates, generate higher levels of ROS and sustain
ROS damage [23,24]. Consequently, the mitochondria of can-
cer cells undergo many and varied constitutional changes
[26–28]. A functional and universal adaptation to the high met-
abolic and oxidative state of cancer cells is a marked shift to-
wards anaerobic metabolism [29,30]. This fundamental
property, termed the Warburg eﬀect, is characterized by an in-
crease in glucose uptake and lactic acid production. However,
the Warburg eﬀect does not imply that there is a decrease aer-
obic respiration, to mitigate ROS production [29,30]. In fact,
mitochondrial ROS production is maximal, during state-4 res-
piration (resting), and minimal during state-3 respiration
(active), indicating a far more complex relation between oxy-
gen consumption, respiratory chain activity and ROS produc-
tion [31–33]. In the model system under investigation, there
were no signiﬁcant changes in glucose uptake, lactic acid pro-
duction and oxygen consumption in mI-jB-Line 1 relative to
WT-Line 1 cells (data not shown).
The metabolic nuclear receptors are nutrient and toxicolog-
ical sensors that integrate the homoestatic control of glucose,
lipid and energy metabolism [reviewed in [34–36]]. To under-
stand the implications of upregulated NHRs in mI-jB-Line 1Line 1 and mI-jB-Line 1 cells was performed as described in Section 2.
arative dataset for diﬀerentially expressed genes (supplemental dataset
ar hormone receptors (NHRs) and regulators of NHR function were
c extracted using Treeview software [50].
Fig. 2. Downregulation of antioxidant enzymes in mI-jB-Line 1 cells, correlates with increased levels of ROS and ROS damage to cellular
macromolecules. ROS levels and ROS damage is minimized by an array of protective mechanisms. The ﬁrst line of defense involves the conversion
the superoxide anions to hydrogen peroxide (H2O2) by mitochondrial MnSOD and cytosolic Cu/ZnSOD. The detrimental eﬀects of H2O2 are
prevented by glutathione peroxidase (GPX) through oxido-reductive coupling reactions with glutathione (GSH). Additional protection is provided
by Catalase (CAT), which converts H2O2 to H2O and O2 notably in the peroxisomes. (A) and (B) demonstrate suppression of antioxidant enzymes at
the gene and protein levels, respectively. (C) Higher levels of ROS (ﬂuorescence intensity in the cells) and correspondingly, (D) increased lipid
peroxidation products notably the malonyldialdehyde and 4-hydroxy nonenal (4HNE) (E) increased ﬂuorescent staining of protein – 4HNE adducts
(100· magniﬁcation) and (F) inceased genotoxicity, assessed by increased nuclear staining with for 8-hydroxy guanosine adducts (data not shown)
and conﬁrmed with the comet assay (100·). * Indicates a statistically signiﬁcant result (P < 0.05).
6818 V.B. Andela et al. / FEBS Letters 579 (2005) 6814–6820cells, we previously studied the pharmacologic activation of
PPAR c in parental Line 1 cells and reported a dose dependent
induction of lipogenic enzymes, an increase in glucose uptake
and a shift in energy metabolism towards fatty acid oxidation
(b-oxidative respiration) [37]. Drawing from this study, we
probed for diﬀerences in the energy metabolism of WT-Line
1 and mI-jB-Line 1 cells, by inhibiting glycolysis and fatty acid
oxidation (Fig. 3). Our results indicate that mI-jB-Line
cells are equally dependent on glycolysis, but become markedlyreliant on fatty acid oxidation (b-oxidative respiration) for en-
ergy metabolism.
Based on these observations, we propose a dynamic model
that rests on established biochemical precepts, notably that:
(A) The expression and activity of the pyruvate dehydroge-
nase complex (PDC), which integrates the reciprocal regula-
tion of the glucose-fatty acid cycle (Randle eﬀect) [38], is
highly redox sensitive [39–41]. Thus highly charged cells,
e.g., the cardiac myocyte [42,43], transformed cells [44] and
Fig. 3. Chronic oxidative stress in mI-jB-Line 1 cells is accompanied by compensatory metabolic adaptations, which include a shift in energy
metabolism towards b-oxidative respiration. (A) WT and mI-jB-Line 1 cells were treated with either the glucose analog and anti-metabolite, 2-
deoxyglucose (2-DG) or the inhibitor of fatty acid oxidation, trimetazidine (TMZ), for 36 h. The induction of Caspase 3 activity, an early indicator of
apoptosis, was assessed. The results represent the average ± S.E. of three independent experiments. *P < 0.05, **P < 0.001 in mI-jB-Line 1 relative
to the WT-Line 1 treatment group. (B) Cell viability following 36 h treatment with 2-DG (100 mM) and TMZ (3 mM) was assessed by trypan blue
exclusion and (C) Cellular levels of ATP were determined and normalized to viable cell count. The results represent the mean ± S.E. of four
independent experiments. **P < 0.03 in mI-jB-Line 1 relative to WT-Line 1 treatment group.
V.B. Andela et al. / FEBS Letters 579 (2005) 6814–6820 6819case in point, mI-jB-Line 1 cells, direct pyruvate (the end
product of glycolysis) toward fatty acid synthesis and oxida-
tion. From the standpoint of cellular bioenergetics, this is
more favorable, granted more ATP is derived from oxidizing
a molecule of palmitate (a 6-carbon chain fatty acid) than a
molecule of glucose. Furthermore, fatty acids are ‘‘mild
uncouplers’’ of the respiratory chain [45,46], and as such, mit-
igate ROS production and damage. (B) The products of gly-
colysis are shunted towards restorative and anabolic
pathways such as redox control, fatty acid and nucleotide
synthesis (ribose-5-phosphate) [47,48]. While tenable, this
model does not incorporate other fuel sources; the varied
constitutional changes in the mitochondria of transformed
cells and multiple levels of nutrient and toxicological signal
integration. The integration of datasets from large-scale gene
expression and metabolic proﬁle [32,49] would clarify the pic-
ture and yield insights that would positively bear on cancer
diagnostic, preventive and therapeutic interventions.Acknowledgements: Drs. Tzong-Jen Sheu, Yi-Jang Lee and Saleh Alt-
uwaijri for their assistance with the real-time PCR analyses, comet as-
says and apoptosis assays, respectively. This work, was in part,
supported by the James P. Wilmot Foundation through a Wilmot
fellowship award to V.B.A.Appendix A. Supplementary data
Supplementary data associated with this article can be found,
in the online version, at doi:10.1016/j.febslet.2005.11.018.
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